AKSO Announces Publication of Preclinical Data Demonstrating Engineered Soluble BCMA Decoy Receptor AB001 Effectively Inhibits Multiple Myeloma and Diffuse Large B Cell Lymphoma

LOS ANGELES & LONDON & BEIJING--(BUSINESS WIRE)--AKSO Announces Publication of Preclinical Data for DEEP Engineered Soluble BCMA Decoy Receptor AB001

Click to view original post